Molecular Imaging Reveals a Role for AKT in Resistance to Cisplatin for Ovarian Endometrioid Adenocarcinoma

PURPOSE: Ovarian cancer is the fifth leading cause of cancer deaths among American women. Platinum-based chemotherapy, such as cisplatin, represents the standard of care for ovarian cancer. However, toxicity and acquired resistance to cisplatin have proven challenging in the treatment of ovarian can...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Wang, Hanxiao, Galbán, Stefanie, Wu, Rong, Bowman, Brittany, Witte, Amanda, Vetter, Katrin, Galbán, Craig J., Ross, Brian D., Cho, Kathleen R., Rehemtulla, Alnawaz
Formato: Artigo
Lenguaje:Inglês
Publicado: 2012
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3537896/
https://ncbi.nlm.nih.gov/pubmed/23095324
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-12-2380
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares